These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37952936)

  • 1. Sugar-Rich Food Intake Is Negatively Associated with Plasma Pentraxin 3 Levels.
    Zempo-Miyaki A; Kumagai H; Tanahashi K; Zempo H; Otsuki T; Maeda S
    J Obes Metab Syndr; 2023 Dec; 32(4):330-337. PubMed ID: 37952936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity and high waist circumference are associated with low circulating pentraxin-3 in acute coronary syndrome.
    Barazzoni R; Aleksova A; Carriere C; Cattin MR; Zanetti M; Vinci P; Stolfo D; Guarnieri G; Sinagra G
    Cardiovasc Diabetol; 2013 Nov; 12():167. PubMed ID: 24215445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentraxin 3 increases in adult overweight and obese men after weight loss by dietary modification with exercise training.
    Zempo-Miyaki A; Kumagai H; Yoshikawa T; Myoenzono K; So R; Otsuki T; Tanaka K; Maeda S
    Appl Physiol Nutr Metab; 2019 Feb; 44(2):111-117. PubMed ID: 29990442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise reduced pentraxin 3 levels produced by endotoxin-stimulated human peripheral blood mononuclear cells in obese individuals.
    Slusher AL; Shibata Y; Whitehurst M; Maharaj A; Quiles JM; Huang CJ
    Exp Biol Med (Maywood); 2017 Jun; 242(12):1279-1286. PubMed ID: 28440716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationships between sugar-sweetened beverage intake and cardiometabolic markers in young children.
    Kosova EC; Auinger P; Bremer AA
    J Acad Nutr Diet; 2013 Feb; 113(2):219-27. PubMed ID: 23351625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Plasma Pentraxin-3 Level with Lipid Levels and Cardiovascular Risk Factors in People with No History of Lipid-Lowering Medication: the Dong-gu Study.
    Lee R; Ahn HR; Shin MH; Kim HN; Lee YH; Choi SW; Kweon SS
    J Atheroscler Thromb; 2019 Aug; 26(8):738-745. PubMed ID: 30674758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between insulin resistance-associated metabolic parameters and anthropometric measurements with sugar-sweetened beverage intake and physical activity levels in US adolescents: findings from the 1999-2004 National Health and Nutrition Examination Survey.
    Bremer AA; Auinger P; Byrd RS
    Arch Pediatr Adolesc Med; 2009 Apr; 163(4):328-35. PubMed ID: 19349561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between plasma pentraxin 3 level and risk of chronic kidney disease in the Korean elderly: the Dong-gu study.
    Lee R; Shin MH; Kim HN; Lee YH; Choi SW; Ahn HR; Kweon SS
    Int Urol Nephrol; 2017 Nov; 49(11):2027-2033. PubMed ID: 28733767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of obesity on pentraxin 3 and inflammatory milieu to acute aerobic exercise.
    Slusher AL; Mock JT; Whitehurst M; Maharaj A; Huang CJ
    Metabolism; 2015 Feb; 64(2):323-9. PubMed ID: 25467846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reciprocal contribution of pentraxin 3 and C-reactive protein to obesity and metabolic syndrome.
    Ogawa T; Kawano Y; Imamura T; Kawakita K; Sagara M; Matsuo T; Kakitsubata Y; Ishikawa T; Kitamura K; Hatakeyama K; Asada Y; Kodama T
    Obesity (Silver Spring); 2010 Sep; 18(9):1871-4. PubMed ID: 20111016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory biomarker pentraxin 3 (PTX3) in relation to obesity, body fat depots and weight loss.
    Witasp A; Carrero JJ; Michaëlsson K; Ahlström H; Kullberg J; Adamsson V; Risérus U; Larsson A; Helmersson-Karlqvist J; Lind L; Stenvinkel P; Arnlöv J
    Obesity (Silver Spring); 2014 May; 22(5):1373-9. PubMed ID: 24415446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of pentraxin 3 with insulin resistance and glucose response following maximal aerobic exercise in obese and normal-mass individuals.
    Slusher AL; Huang CJ
    Can J Physiol Pharmacol; 2016 Jul; 94(7):734-8. PubMed ID: 27152505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma pentraxin 3 levels do not predict coronary events but reflect metabolic disorders in patients with coronary artery disease in the CARE trial.
    Miyazaki T; Chiuve S; Sacks FM; Ridker PM; Libby P; Aikawa M
    PLoS One; 2014; 9(4):e94073. PubMed ID: 24705587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does low pentraxin-3 levels associate with polycystic ovary syndrome and obesity?
    Sahin FK; Sahin SB; Balik G; Ural UM; Tekin YB; Cure MC; Senturk S; Yuce S; Cure E
    Int J Clin Exp Med; 2014; 7(10):3512-9. PubMed ID: 25419391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Habitual aerobic exercise increases plasma pentraxin 3 levels in middle-aged and elderly women.
    Miyaki A; Maeda S; Choi Y; Akazawa N; Tanabe Y; Ajisaka R
    Appl Physiol Nutr Metab; 2012 Oct; 37(5):907-11. PubMed ID: 22784030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric bypass-induced weight loss alters obesity-associated patterns of plasma pentraxin-3 and systemic inflammatory markers.
    Barazzoni R; Palmisano S; Gortan Cappellari G; Giuricin M; Moretti E; Vinci P; Semolic A; Guarnieri G; Zanetti M; Manzini Nd
    Surg Obes Relat Dis; 2016 Jan; 12(1):23-32. PubMed ID: 26277450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma Pentraxin 3 as a biomarker of metabolic syndrome.
    Kardas F; Akın L; Kurtoglu S; Kendirci M; Kardas Z
    Indian J Pediatr; 2015 Jan; 82(1):35-8. PubMed ID: 25065938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating pentraxin 3 levels are higher in metabolic syndrome with subclinical atherosclerosis: evidence for association with atherogenic lipid profile.
    Zanetti M; Bosutti A; Ferreira C; Vinci P; Biolo G; Fonda M; Valente M; Cattin L; Guarnieri G; Barazzoni R
    Clin Exp Med; 2009 Sep; 9(3):243-8. PubMed ID: 19238513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Environmental interventions to reduce the consumption of sugar-sweetened beverages and their effects on health.
    von Philipsborn P; Stratil JM; Burns J; Busert LK; Pfadenhauer LM; Polus S; Holzapfel C; Hauner H; Rehfuess E
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012292. PubMed ID: 31194900
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.